These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 26530486

  • 1. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
    Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW.
    Endocr Pathol; 2015 Dec; 26(4):365-9. PubMed ID: 26530486
    [Abstract] [Full Text] [Related]

  • 2. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
    Topf MC, Wang ZX, Furlong K, Miller JL, Tuluc M, Pribitkin EA.
    Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
    [Abstract] [Full Text] [Related]

  • 3. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA.
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [Abstract] [Full Text] [Related]

  • 4. Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid.
    Tong GX, Mody K, Wang Z, Hamele-Bena D, Nikiforova MN, Nikiforov YE.
    Endocr Pathol; 2015 Dec; 26(4):315-9. PubMed ID: 26260781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
    Qasem E, Murugan AK, Al-Hindi H, Xing M, Almohanna M, Alswailem M, Alzahrani AS.
    Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
    Evangelisti C, de Biase D, Kurelac I, Ceccarelli C, Prokisch H, Meitinger T, Caria P, Vanni R, Romeo G, Tallini G, Gasparre G, Bonora E.
    BMC Cancer; 2015 Mar 21; 15():157. PubMed ID: 25880213
    [Abstract] [Full Text] [Related]

  • 15. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
    Segev DL, Saji M, Phillips GS, Westra WH, Takiyama Y, Piantadosi S, Smallridge RC, Nishiyama RH, Udelsman R, Zeiger MA.
    J Clin Endocrinol Metab; 1998 Jun 21; 83(6):2036-42. PubMed ID: 9626136
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.